Sovereign-backed Bioscript snaps up Triducive
Thursday, May 7, 2026 · first reported by PE Hub
Sovereign-backed Bioscript acquired Triducive, a life sciences clinical opinion consultancy.
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore in Deals
From the same day- Intertek poised to Reject EQT’s sweetened £10bn bidPrivate Equity Wire
- Ametek strikes $5bn deal CD&R’s for Indicor Instrumentation AssetsPrivate Equity Wire
- Carlyle and Diversified Energy to acquire Andarko Basin oil assets from Camino for $1.2bnPE Hub
- Siris to reap 3x return on Equiniti in sale to Bullish, sources sayPE Hub
- GI Partners rolls out Rose BioSolutionsPE Hub
- Brightstar invests in Simon Eye HoldingsPE Hub